Literature DB >> 7708830

Natural selection at the class II major histocompatibility complex loci of mammals.

A L Hughes1, M K Hughes, C Y Howell, M Nei.   

Abstract

The role of natural selection at major histocompatibility complex (MHC) loci was studied by analysis of molecular sequence data from mammalian class II MHC loci. As found previously for the class I MHC molecule and a hypothetical model of the class II molecule, the rate of non-synonymous nucleotide substitution exceeded that of synonymous substitution in the codons encoding the antigen recognition site of polymorphic class II molecules. This pattern is evidence that the polymorphism at these loci is maintained by a form of balancing selection, such as overdominant selection. By contrast, in the case of monomorphic class II loci, no such enhancement of the rate of non-synonymous substitution was observed. Phylogenetic analysis indicates that, in contrast to monomorphic ('non-classical') class I MHC loci, some monomorphic class II loci of mammals are quite ancient. The DMA and DMB loci, for example, diverged before all other known mammalian class II loci, possibly before the divergence of tetrapods from bony fishes. Analysis of the patterns of sharing of polymorphic residues at class II MHC loci by mammals of different species revealed that extensive convergent evolution has occurred at these loci; but no support was found for the hypothesis that MHC polymorphisms have been maintained since before the divergence of orders of eutherian mammals.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7708830     DOI: 10.1098/rstb.1994.0153

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  25 in total

1.  A comparison of intraspecific patterns of DNA sequence variation in mitochondrial DNA, alpha-enolase, and MHC class II B loci in auklets (Charadriiformes: Alcidae).

Authors:  Hollie E Walsh; Vicki L Friesen
Journal:  J Mol Evol       Date:  2003-12       Impact factor: 2.395

2.  Host-parasite interactions and the evolution of ploidy.

Authors:  Scott L Nuismer; Sarah P Otto
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-13       Impact factor: 11.205

3.  MHC evolution in three salmonid species: a comparison between class II alpha and beta genes.

Authors:  Daniela Gómez; Pablo Conejeros; Sergio H Marshall; Sofia Consuegra
Journal:  Immunogenetics       Date:  2010-06-03       Impact factor: 2.846

4.  Duplication, balancing selection and trans-species evolution explain the high levels of polymorphism of the DQA MHC class II gene in voles (Arvicolinae).

Authors:  J Bryja; M Galan; N Charbonnel; J F Cosson
Journal:  Immunogenetics       Date:  2006-02-09       Impact factor: 2.846

5.  Evolution of MHC class I in the order Crocodylia.

Authors:  Weerachai Jaratlerdsiri; Sally R Isberg; Damien P Higgins; Simon Y W Ho; Jan Salomonsen; Karsten Skjodt; Lee G Miles; Jaime Gongora
Journal:  Immunogenetics       Date:  2013-11-20       Impact factor: 2.846

6.  Codon-based tests of positive selection, branch lengths, and the evolution of mammalian immune system genes.

Authors:  Austin L Hughes; Robert Friedman
Journal:  Immunogenetics       Date:  2008-06-26       Impact factor: 2.846

Review 7.  Natural selection on the peptide-binding regions of major histocompatibility complex molecules.

Authors:  A L Hughes; M K Hughes
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

8.  Evolution by the birth-and-death process in multigene families of the vertebrate immune system.

Authors:  M Nei; X Gu; T Sitnikova
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

9.  Selection on an antimicrobial peptide defensin in ants.

Authors:  Lumi Viljakainen; Pekka Pamilo
Journal:  J Mol Evol       Date:  2008-12       Impact factor: 2.395

10.  Diversifying and purifying selection in the peptide binding region of DRB in mammals.

Authors:  Rebecca F Furlong; Ziheng Yang
Journal:  J Mol Evol       Date:  2008-03-18       Impact factor: 2.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.